Scorpio Tankers Inc. Announces Financial Results for the First Quarter of 2024 and Declaration of a Dividend
May 09, 2024 06:44 ET
|
Scorpio Tankers Inc.
MONACO, May 09, 2024 (GLOBE NEWSWIRE) -- Scorpio Tankers Inc. (NYSE: STNG) ("Scorpio Tankers" or the "Company") today reported its results for the three months ended March 31, 2024. The Company...
Osteoarthritis Market Forecast Reveals Significant Growth and Upcoming Therapeutic Advancements by 2032
May 06, 2024 04:09 ET
|
Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Osteoarthritis - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The report...
ECARX Releases Multiple Intelligent Driving Features for Skyland Pro
May 03, 2024 07:00 ET
|
ECARX LIMITED
SHANGHAI, China, May 03, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology company, today announced the launch of multiple...
INVNT GROUP and MSM Boost Partnership and Marketing Service Offerings in Motorsports Industry with Strategic Leadership Appointment
May 02, 2024 07:18 ET
|
[INVNT GROUP]
New York, NY, May 02, 2024 (GLOBE NEWSWIRE) -- Building on their successful partnership, INVNT GROUP and MSM (Media & Sport Management) enhance service offerings and commercial solutions...
Alvotech tekur þátt í heilbrigðisráðstefnu BofA Securities í Bandaríkjunum
May 02, 2024 07:15 ET
|
Alvotech
Alvotech (NASDAQ: ALVO) tilkynnti í dag að félagið taki þátt í árlegri heilbrigðisráðstefnu BofA Securities, sem haldin verður dagana 14. – 15. maí í Las Vegas, Nevadafylki Bandaríkjanna. Fulltrúar úr...
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
May 02, 2024 07:15 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of management would be...
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
May 02, 2024 07:15 ET
|
Alvotech
REYKJAVIK, Iceland, May 02, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
NIO Inc. Provides April 2024 Delivery Update
May 01, 2024 05:30 ET
|
NIO Inc.
NIO delivered 15,620 vehicles in April 2024, increasing by 134.6% year-over-yearNIO delivered 45,673 vehicles year-to-date in 2024, increasing by 21.2% year-over-year Cumulative deliveries of NIO...
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
April 30, 2024 04:00 ET
|
Alvotech
Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S....
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
April 30, 2024 04:00 ET
|
Alvotech
Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S....